Security Snapshot

Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) Institutional Ownership

CUSIP: 30050B101

13F Institutional Holders and Ownership History from Q2 2015 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

185

Shares (Excl. Options)

110,357,205

Price

$2.28

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-8,082,236
Value change
-$30,211,470
Number of holders
185
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
112,318,617
SEC-reported price per share
$4.16
Insider filing price
$4.16
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share is tracked under CUSIP 30050B101.
  • 185 institutions reported positions in Q1 2026.
  • 8 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 211 to 185 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $482,118,679 to $251,564,325.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 185 institutions filings for Q1 2026.

Open SEC evidence

Security key

30050B101

Latest holder period

Q1 2026

13F holders

185

13D/G owners

8

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
8
Security
EVH
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CADIAN CAPITAL MANAGEMENT, LP 9.3% $106,218,923 10,794,606 Cadian Capital Management, LP 31 Mar 2025
MORGAN STANLEY 8.1% +16% $37,755,903 +$3,682,702 9,097,808 +11% Morgan Stanley 31 Dec 2025
VANGUARD GROUP INC 8% $35,656,260 8,914,065 The Vanguard Group 31 Dec 2025
Boehler Adam 5.2% $49,204,401 5,816,123 Rubicon OP GP II LP 13 Nov 2025
RA CAPITAL MANAGEMENT, L.P. 3.1% $35,199,618 3,577,197 RA Capital Management, L.P. 31 Dec 2024
FMR LLC 0.7% -91% $3,003,548 -$34,663,704 750,887 -92% FMR LLC 31 Dec 2025
WELLINGTON MANAGEMENT GROUP LLP 0.4% -96% $5,016,947 -$113,228,542 442,802 -96% Wellington Management Group LLP 30 Jun 2025
EVENTIDE ASSET MANAGEMENT, LLC 0% -108% $7,109 -$26,106,812 1,713 -100% Eventide Asset Management, LLC 31 Dec 2025

As of 31 Mar 2026, 185 institutional investors reported holding 110,357,205 shares of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH). This represents 98% of the company’s total 112,318,617 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
82%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 9.7% 10,888,872 +5.4% 0% $24,826,629
CADIAN CAPITAL MANAGEMENT, LP 9.6% 10,814,473 -2.4% 3% $24,656,998
MORGAN STANLEY 8.1% 9,081,078 -2.1% 0% $20,704,857
UBS Group AG 7.3% 8,150,361 +33% 0% $18,582,823
Rubicon Founders LLC 5.2% 5,816,123 0% 9.6% $13,260,760
Engaged Capital LLC 5% 5,563,912 0% 4.2% $12,685,719
D. E. Shaw & Co., Inc. 4.8% 5,434,032 +3.1% 0.01% $12,389,593
VANGUARD CAPITAL MANAGEMENT LLC 4.3% 4,867,403 0% 0% $11,097,679
Rock Springs Capital Management LP 2.4% 2,675,000 0% 0.36% $6,099,000
STATE STREET CORP 2.4% 2,646,398 -10% 0% $6,033,787
GEODE CAPITAL MANAGEMENT, LLC 2.3% 2,618,425 -4.2% 0% $5,971,683
MAVERICK CAPITAL LTD 2.3% 2,572,763 +1.3% 0.07% $5,865,900
EVENTIDE ASSET MANAGEMENT, LLC 2.3% 2,547,558 0.1% $5,808,432
GOLDMAN SACHS GROUP INC 2% 2,236,606 +22% 0% $5,099,461
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.7% 1,949,446 +29% 0% $4,444,737
Tejara Capital Ltd 1.7% 1,946,650 +46% 1.5% $4,438,362
DIMENSIONAL FUND ADVISORS LP 1.6% 1,790,298 -22% 0% $4,081,230
JANE STREET GROUP, LLC 1.6% 1,790,147 -39% 0% $4,081,536
Rock Point Advisors, LLC 1.6% 1,786,681 +50% 1.1% $4,073,633
HRT FINANCIAL LP 1.5% 1,726,196 +148% 0.01% $3,935,000
KENNEDY CAPITAL MANAGEMENT LLC 1.4% 1,597,615 +73% 0.08% $3,642,562
Hudson Bay Capital Management LP 1.2% 1,316,420 -9.8% 0.02% $3,001,438
VANGUARD PORTFOLIO MANAGEMENT LLC 0.83% 930,878 0% 0% $2,122,402
NORTHERN TRUST CORP 0.82% 917,137 -13% 0% $2,091,072
BNP PARIBAS FINANCIAL MARKETS 0.79% 891,403 0% 0% $2,032,399

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
44
Latest
Q1 2026
Rows shown
1-25 of 44
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 110,357,205 $251,564,325 -$30,211,470 $2.28 185
2025 Q4 120,528,795 $482,118,679 -$146,972,693 $4.00 211
2025 Q3 135,659,696 $1,147,817,881 +$12,305,118 $8.46 237
2025 Q2 131,673,312 $1,482,570,130 +$78,519,495 $11.26 218
2025 Q1 125,716,823 $1,190,564,177 +$20,137,898 $9.47 222
2024 Q4 122,283,963 $1,375,271,472 -$248,054,960 $11.25 237
2024 Q3 129,270,440 $3,653,744,995 +$36,997,360 $28.28 255
2024 Q2 129,502,142 $2,475,760,428 +$40,167,326 $19.12 239
2024 Q1 125,850,762 $4,125,692,137 -$4,762,881 $32.79 247
2023 Q4 126,464,041 $4,176,843,783 +$156,108,720 $33.03 232
2023 Q3 122,189,782 $3,342,247,641 +$125,298,418 $27.23 201
2023 Q2 117,663,348 $3,553,501,314 +$168,830,769 $30.30 216
2023 Q1 111,825,275 $3,615,108,333 +$350,007,462 $32.45 237
2022 Q4 101,432,734 $2,846,879,147 +$146,714,497 $28.08 229
2022 Q3 95,515,991 $3,431,522,864 +$214,834,478 $35.93 243
2022 Q2 89,722,827 $2,755,609,040 +$99,219,171 $30.71 207
2022 Q1 86,524,226 $2,793,511,290 +$66,700,981 $32.30 208
2021 Q4 84,687,344 $2,342,026,098 -$26,236,636 $27.67 200
2021 Q3 85,614,905 $2,649,865,771 +$83,228,566 $31.00 205
2021 Q2 83,046,124 $1,753,120,165 +$24,126,478 $21.12 175
2021 Q1 81,962,439 $1,657,194,786 +$54,461,956 $20.20 163
2020 Q4 81,531,166 $1,307,117,041 +$30,502,553 $16.03 153
2020 Q3 79,968,182 $996,864,007 +$91,919,009 $12.41 147
2020 Q2 73,419,664 $521,944,449 -$8,509,221 $7.12 127
2020 Q1 76,262,366 $412,459,741 -$45,659,323 $5.43 144
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .